Ongoing Research BPC-157 + TB-500 remains an active area of investigation across regenerative biology, connective tissue physiology, musculoskeletal research, vascular biology, and peptide pharmacology
Emerg Med J 25:3337 Stambolija V, Stambolija TP, Holjevac JK, Murselovic T, Radonic J, Duzel V, Duplancic B, Uzun S, Zivanovic-Posilovic G, Kolenc D, Drmic D (2016) BPC 157: the counteraction of succinylcholine, hyperkalemia, and arrhythmias
Biology and clinical use of glucagon-like peptide-1 receptor agonists in vascular protection
instead, it appears to work by modulating pathways like vascular endothelial growth factor (VEGF) and nitric oxide to promote healing
It is sold for laboratory and scientific investigation only